Platinum Equity
Mergers. Acquisitions. Operations.
 

Mergers. Acquisitions. Operations.

LifeScan

Healthcare • Corporate Divestiture • Acquired in October 2018

A healthcare leader in glucose management – delivering personalized health and wellness experiences

LifeScan, a Platinum Equity Portfolio Company, provides of blood glucose monitoring products and solutions.

KEY FACTS

  • Platinum acquired LifeScan, Inc. from Johnson & Johnson in October 2018 in a complex carve-out, with the business achieving stability and growth in 2020 and beyond.
  • LifeScan is the maker of the iconic OneTouch® brand of glucose management products and solutions, focused on connected, integrated blood glucose management (meters, test strips, lancing devices) with an integrated digital health platform offering a variety of solutions for hospital and non-hospital use.
  • OneTouch® products are used by more than 20 million consumers around the world in over 70 countries.
  • Expanding connected consumer base with the majority of the blood glucose meters placed each year being Bluetooth-enabled.  The global digital ecosystem consists of 240,000 app users per month, growing with over 78,000 new app downloads per month.
  • LifeScan offers world-class educational opportunities for healthcare professionals through the LifeScan Diabetes Institute.
  • Company has over 2,100 employees, a best-in-class manufacturing facility in Inverness, Scotland and is headquartered in Malvern, PA.

INITIATIVES

  • Grow core blood glucose management volume, beating the category, and broaden reach with digital solutions, data and health outcomes, partnerships and new channels.
  • Achieve the lowest cost position.
  • Continue to streamline operating model.
  • Launch Continuous Glucose monitoring (CGM) and new digital health solutions.

 

NEWS

Platinum Equity Submits Binding Offer to Acquire LifeScan from Johnson & Johnson »

Johnson & Johnson Announces Acceptance of Binding Offer From Platinum Equity To Acquire LifeScan, Inc. »


Platinum Equity Completes $2.1 Billion Acquisition of LifeScan from Johnson & Johnson »

 

updated 9/21


 
Close

E-mail

*
*
*
*

Signing up for our Newsletter is subject to our Privacy Notice. You may unsubscribe at any time.

We are strongly committed to protecting your privacy. By submitting your contact information, you acknowledge that you have read our Privacy Notice and that you consent to our processing of data in accordance with our Privacy Notice.